Menu
Back to User profile » Dr Yingen Luo
Papers published by Dr Yingen Luo:
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]
Yang H, Cong T, Luo Y, Yang C, Ren J, Li X
Journal of Hepatocellular Carcinoma 2024, 11:563-564
Published Date: 14 March 2024
A Novel Rat Model to Simulate the Benign Esophageal Stricture Induced by Endoscopic Submucosal Dissection
Luo YG, Zhang XW, Zhao H, Li JG, Tsauo JW, Gong T, Ou AX, Cong TH, Kang WD, Li X
Clinical and Experimental Gastroenterology 2024, 17:41-50
Published Date: 19 February 2024
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy
Yang H, Cong T, Luo Y, Yang C, Ren J, Li X
Journal of Hepatocellular Carcinoma 2024, 11:175-189
Published Date: 24 January 2024
The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels
Cong T, Yang C, Cao Q, Ren J, Luo Y, Yuan P, Zheng B, Liu Y, Yang H, Kang W, Ou A, Li X
Journal of Hepatocellular Carcinoma 2024, 11:95-111
Published Date: 17 January 2024
Modified Patent Hemostasis Strategy Based on the Platelet Counts for Transradial Access Chemoembolization in Patients with Hepatocellular Carcinoma: A Prospective Single-Center Study
Luo YG, Zhang XW, Tsauo JW, Li Y, Li JG, Peng Q, Li YW, Sun W, Zhao H, Li X
Journal of Hepatocellular Carcinoma 2023, 10:687-695
Published Date: 21 April 2023
Effects of Early TACE Refractoriness on Survival in Patients with Hepatocellular Carcinoma: A Real-World Study
Yang C, Luo YG, Yang HC, Yao ZH, Li X
Journal of Hepatocellular Carcinoma 2022, 9:621-631
Published Date: 21 July 2022